A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing
- Disease/Condition
- Ventricular Arrythmia
- Drug/Device/Intervention
- ommitence of defibrillation testing
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Location
- Orlando,Atlanta,Chicago,Englewood,New York,New York,Chattanooga,Hamburg,Kiel,Lübeck,Mannheim,Würzburg,Almere,Amsterdam,Amsterdam,Dordrecht,Eindhoven,Groningen,Haarlem,Leeuwarden,Nieuwegein,Nijmegen,Zw, Germany,Netherlands,United Kingdom,United States of America
- Phase
- N/A
- Start date
- May 07, 2018
- End date
- Oct 01, 2024
- Enrollment
- 965 participants
Failed first appropriate shock in a spontaneous episode
This study will test the hypothesis that implantation of a subcutaneous implantable
 cardioverter defibrillator (S-ICD) without performing a defibrillation test is non-inferior
 to S-ICD implant with a defibrillation test with regards to the primary endpoint failed first
 shock in a spontaneous arrhythmia episode when implant position is confirmed with PRAETORIAN
 score.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT03495297
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT03495297 through Pure Global AI's free database. This phase not specified trial is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and is currently Active, not recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 965 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.